Copyright Reports & Markets. All rights reserved.

Global Inhaled Corticosteroid Market Research Report 2021

Request for Sample of this report
Buy now

1 Inhaled Corticosteroid Market Overview

  • 1.1 Product Overview and Scope of Inhaled Corticosteroid
  • 1.2 Inhaled Corticosteroid Segment by Type
    • 1.2.1 Global Inhaled Corticosteroid Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Beclomethasone Dipropionate
    • 1.2.3 Budesonide
    • 1.2.4 Fluticasone Inhaler Powder
    • 1.2.5 Mometasone
    • 1.2.6 Others
  • 1.3 Inhaled Corticosteroid Segment by Application
    • 1.3.1 Inhaled Corticosteroid Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Respiratory Care Centers
    • 1.3.5 Others
  • 1.4 Global Inhaled Corticosteroid Market Size Estimates and Forecasts
    • 1.4.1 Global Inhaled Corticosteroid Revenue 2016-2027
    • 1.4.2 Global Inhaled Corticosteroid Sales 2016-2027
    • 1.4.3 Inhaled Corticosteroid Market Size by Region: 2016 Versus 2021 Versus 2027

2 Inhaled Corticosteroid Market Competition by Manufacturers

  • 2.1 Global Inhaled Corticosteroid Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Inhaled Corticosteroid Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Inhaled Corticosteroid Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Inhaled Corticosteroid Manufacturing Sites, Area Served, Product Type
  • 2.5 Inhaled Corticosteroid Market Competitive Situation and Trends
    • 2.5.1 Inhaled Corticosteroid Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Inhaled Corticosteroid Players Market Share by Revenue
    • 2.5.3 Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inhaled Corticosteroid Retrospective Market Scenario by Region

  • 3.1 Global Inhaled Corticosteroid Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Inhaled Corticosteroid Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Inhaled Corticosteroid Market Facts & Figures by Country
    • 3.3.1 North America Inhaled Corticosteroid Sales by Country
    • 3.3.2 North America Inhaled Corticosteroid Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Inhaled Corticosteroid Market Facts & Figures by Country
    • 3.4.1 Europe Inhaled Corticosteroid Sales by Country
    • 3.4.2 Europe Inhaled Corticosteroid Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Inhaled Corticosteroid Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Inhaled Corticosteroid Sales by Region
    • 3.5.2 Asia Pacific Inhaled Corticosteroid Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Inhaled Corticosteroid Market Facts & Figures by Country
    • 3.6.1 Latin America Inhaled Corticosteroid Sales by Country
    • 3.6.2 Latin America Inhaled Corticosteroid Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Inhaled Corticosteroid Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Inhaled Corticosteroid Sales by Country
    • 3.7.2 Middle East and Africa Inhaled Corticosteroid Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Inhaled Corticosteroid Historic Market Analysis by Type

  • 4.1 Global Inhaled Corticosteroid Sales Market Share by Type (2016-2021)
  • 4.2 Global Inhaled Corticosteroid Revenue Market Share by Type (2016-2021)
  • 4.3 Global Inhaled Corticosteroid Price by Type (2016-2021)

5 Global Inhaled Corticosteroid Historic Market Analysis by Application

  • 5.1 Global Inhaled Corticosteroid Sales Market Share by Application (2016-2021)
  • 5.2 Global Inhaled Corticosteroid Revenue Market Share by Application (2016-2021)
  • 5.3 Global Inhaled Corticosteroid Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Sumitomo
    • 6.1.1 Sumitomo Corporation Information
    • 6.1.2 Sumitomo Description and Business Overview
    • 6.1.3 Sumitomo Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Sumitomo Product Portfolio
    • 6.1.5 Sumitomo Recent Developments/Updates
  • 6.2 Pfizer
    • 6.2.1 Pfizer Corporation Information
    • 6.2.2 Pfizer Description and Business Overview
    • 6.2.3 Pfizer Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Pfizer Product Portfolio
    • 6.2.5 Pfizer Recent Developments/Updates
  • 6.3 Novartis
    • 6.3.1 Novartis Corporation Information
    • 6.3.2 Novartis Description and Business Overview
    • 6.3.3 Novartis Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Novartis Product Portfolio
    • 6.3.5 Novartis Recent Developments/Updates
  • 6.4 Merck
    • 6.4.1 Merck Corporation Information
    • 6.4.2 Merck Description and Business Overview
    • 6.4.3 Merck Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Merck Product Portfolio
    • 6.4.5 Merck Recent Developments/Updates
  • 6.5 Sanofi
    • 6.5.1 Sanofi Corporation Information
    • 6.5.2 Sanofi Description and Business Overview
    • 6.5.3 Sanofi Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Sanofi Product Portfolio
    • 6.5.5 Sanofi Recent Developments/Updates
  • 6.6 Johnson and Johnson
    • 6.6.1 Johnson and Johnson Corporation Information
    • 6.6.2 Johnson and Johnson Description and Business Overview
    • 6.6.3 Johnson and Johnson Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Johnson and Johnson Product Portfolio
    • 6.6.5 Johnson and Johnson Recent Developments/Updates
  • 6.7 GSK
    • 6.6.1 GSK Corporation Information
    • 6.6.2 GSK Description and Business Overview
    • 6.6.3 GSK Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 GSK Product Portfolio
    • 6.7.5 GSK Recent Developments/Updates
  • 6.8 AstraZeneca
    • 6.8.1 AstraZeneca Corporation Information
    • 6.8.2 AstraZeneca Description and Business Overview
    • 6.8.3 AstraZeneca Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 AstraZeneca Product Portfolio
    • 6.8.5 AstraZeneca Recent Developments/Updates
  • 6.9 Teijin
    • 6.9.1 Teijin Corporation Information
    • 6.9.2 Teijin Description and Business Overview
    • 6.9.3 Teijin Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Teijin Product Portfolio
    • 6.9.5 Teijin Recent Developments/Updates
  • 6.10 Glaxo's Advair
    • 6.10.1 Glaxo's Advair Corporation Information
    • 6.10.2 Glaxo's Advair Description and Business Overview
    • 6.10.3 Glaxo's Advair Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Glaxo's Advair Product Portfolio
    • 6.10.5 Glaxo's Advair Recent Developments/Updates
  • 6.11 Amgen
    • 6.11.1 Amgen Corporation Information
    • 6.11.2 Amgen Inhaled Corticosteroid Description and Business Overview
    • 6.11.3 Amgen Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Amgen Product Portfolio
    • 6.11.5 Amgen Recent Developments/Updates
  • 6.12 Kos Pharmaceutical
    • 6.12.1 Kos Pharmaceutical Corporation Information
    • 6.12.2 Kos Pharmaceutical Inhaled Corticosteroid Description and Business Overview
    • 6.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Kos Pharmaceutical Product Portfolio
    • 6.12.5 Kos Pharmaceutical Recent Developments/Updates
  • 6.13 Teva Pharmaceutical
    • 6.13.1 Teva Pharmaceutical Corporation Information
    • 6.13.2 Teva Pharmaceutical Inhaled Corticosteroid Description and Business Overview
    • 6.13.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Teva Pharmaceutical Product Portfolio
    • 6.13.5 Teva Pharmaceutical Recent Developments/Updates

7 Inhaled Corticosteroid Manufacturing Cost Analysis

  • 7.1 Inhaled Corticosteroid Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Inhaled Corticosteroid
  • 7.4 Inhaled Corticosteroid Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Inhaled Corticosteroid Distributors List
  • 8.3 Inhaled Corticosteroid Customers

9 Inhaled Corticosteroid Market Dynamics

  • 9.1 Inhaled Corticosteroid Industry Trends
  • 9.2 Inhaled Corticosteroid Growth Drivers
  • 9.3 Inhaled Corticosteroid Market Challenges
  • 9.4 Inhaled Corticosteroid Market Restraints

10 Global Market Forecast

  • 10.1 Inhaled Corticosteroid Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Inhaled Corticosteroid by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Inhaled Corticosteroid by Type (2022-2027)
  • 10.2 Inhaled Corticosteroid Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Inhaled Corticosteroid by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Inhaled Corticosteroid by Application (2022-2027)
  • 10.3 Inhaled Corticosteroid Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Inhaled Corticosteroid by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Inhaled Corticosteroid by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Beclomethasone Dipropionate
    Budesonide
    Fluticasone Inhaler Powder
    Mometasone
    Others

    Segment by Application
    Hospitals
    Clinics
    Respiratory Care Centers
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Sumitomo
    Pfizer
    Novartis
    Merck
    Sanofi
    Johnson and Johnson
    GSK
    AstraZeneca
    Teijin
    Glaxo's Advair
    Amgen
    Kos Pharmaceutical
    Teva Pharmaceutical

    Buy now